Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
SATVEER K. Mahil, THOMASIN C. Andrews, CHARLOTTE Brierley, JONATHAN N. Barker & CATHERINE H. Smith. (2013) Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature. Journal of Dermatological Treatment 24:1, pages 38-49.
Read now
Read now
Cecilia Mercieca, Norbert Vella & Andrew A. Borg. (2012) Demyelination during anti-TNFα therapy for ankylosing spondylitis. Modern Rheumatology 22:2, pages 303-307.
Read now
Read now
Todd A Kerensky, Alice B Gottlieb, Shimrat Yaniv & Shiu-chung Au. (2012) Etanercept: efficacy and safety for approved indications. Expert Opinion on Drug Safety 11:1, pages 121-139.
Read now
Read now
Léia CR Silva, Luciena CM Ortigosa & Gil Benard. (2010) Anti-TNF-α Agents in the Treatment of Immune-Mediated Inflammatory Diseases: Mechanisms of Action and Pitfalls. Immunotherapy 2:6, pages 817-833.
Read now
Read now
Articles from other publishers (24)
Jin Sun Kim, Mu-Hong Chen, Hohui E. Wang, Ching-Liang Lu, Yen-Po Wang & Bing Zhang. (2023) Inflammatory Bowel Disease and Neurodegenerative Diseases. Gut and Liver 17:4, pages 495-504.
Crossref
Crossref
Jean-Guillaume Letarouilly, Patrick Vermersch & René-Marc Flipo. (2023) Therapeutic consequences in patients with both inflammatory rheumatic diseases and multiple sclerosis. Rheumatology 62:7, pages 2352-2359.
Crossref
Crossref
Sueli Carneiro, Penelope Esther Palominos, Sônia Maria Alvarenga Anti, Rodrigo Luppino Assad, Rafaela Silva Guimarães Gonçalves, Adriano Chiereghin, Andre Marun Lyrio, Antônio Carlos Ximenes, Carla Gonçalves Saad, Célio Roberto Gonçalves, Charles Lubianca Kohem, Cláudia Diniz Lopes Marques, Cláudia Goldenstein Schainberg, Eduardo de Souza Meirelles, Gustavo Gomes Resende, Lenise Brandao Pieruccetti, Mauro Waldemar Keiserman, Michel Alexandre Yazbek, Percival Degrava Sampaio-Barros, Ricardo da Cruz Lage, Rubens Bonfiglioli, Thauana Luíza Oliveira, Valderílio Feijó Azevedo, Washington Alves Bianchi, Wanderley Marques Bernardo, Ricardo dos Santos Simões, Marcelo de Medeiros Pinheiro & Cristiano Barbosa Campanholo. (2021) Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis. Advances in Rheumatology 61:1.
Crossref
Crossref
Sinah Engel, Felix Luessi, Aneka Mueller, Rudolf E. Schopf, Frauke Zipp & Stefan Bittner. (2020) PPMS onset upon adalimumab treatment extends the spectrum of anti-TNF-α therapy-associated demyelinating disorders. Therapeutic Advances in Neurological Disorders 13, pages 175628641989515.
Crossref
Crossref
Yoo Jin Jung, David Tweedie, Michael T. Scerba & Nigel H. Greig. (2019) Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments. Frontiers in Cell and Developmental Biology 7.
Crossref
Crossref
Neha Kumar & Hesham Abboud. (2019) Iatrogenic CNS demyelination in the era of modern biologics. Multiple Sclerosis Journal 25:8, pages 1079-1085.
Crossref
Crossref
Ippazio Cosimo Antonazzo, Emanuel Raschi, Luca Vignatelli, Elisa Baldin, Trond Riise, Roberto D’Alessandro, Fabrizio De Ponti & Elisabetta Poluzzi. (2017) Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping. Drug Safety 40:9, pages 823-834.
Crossref
Crossref
Elissavet Kemanetzoglou & Elisabeth Andreadou. (2017) CNS Demyelination with TNF-α Blockers. Current Neurology and Neuroscience Reports 17:4.
Crossref
Crossref
Yun Dong, Doortje Dekens, Peter De Deyn, Petrus Naudé & Ulrich Eisel. (2015) Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders. Antibodies 4:4, pages 369-408.
Crossref
Crossref
Yana Motuzova, Alessia Di Sapio, Marco Capobianco, Arianna Sala, Fabiana Marnetto, Simona Malucchi & Antonio Bertolotto. (2015) Peculiar Cytological Cerebrospinal Fluid Pattern in a Case of Encephalomyelitis During Anti-Tumor Necrosis Factor-α Therapy. Neurology and Therapy 4:1, pages 53-60.
Crossref
Crossref
Marie Stève-Dumont, Mikael Cohen, Christine Lebrun-Frenay & Fanny Rocher. (2014) Myélite sous anti-TNFα : y penser, même tardivement. Therapies 69:5, pages 473-477.
Crossref
Crossref
Cecilia Mercieca, Irene E. van der Horst-Bruinsma & Andrew A. Borg. (2014) Pulmonary, renal and neurological comorbidities in patients with ankylosing spondylitis; implications for clinical practice. Current Rheumatology Reports 16:8.
Crossref
Crossref
S. Weidauer, M. Nichtweiß & E. Hattingen. (2014) Differential Diagnosis of White Matter Lesions: Nonvascular Causes—Part II. Clinical Neuroradiology 24:2, pages 93-110.
Crossref
Crossref
Evripidis Kaltsonoudis, Paraskevi V. Voulgari, Spyridon Konitsiotis & Alexandros A. Drosos. (2014) Demyelination and other neurological adverse events after anti-TNF therapy. Autoimmunity Reviews 13:1, pages 54-58.
Crossref
Crossref
Amy A. Pruitt. 2014. Neurovirology. Neurovirology
685
704
.
Takumi Matsumoto, Ichiro Nakamura, Ayumi Miura, Gen Momoyama & Katsumi Ito. (2012) New-onset multiple sclerosis associated with adalimumab treatment in rheumatoid arthritis: a case report and literature review. Clinical Rheumatology 32:2, pages 271-275.
Crossref
Crossref
A. Lourbopoulos, P. Ioannidis, E. Boura, D. Antoniadis, D. Karacostas & N. Grigoriadis. (2013) Coexistence of Multiple Sclerosis and Ankylosing Spondylitis: Report of Two Cases. European Neurology 70:3-4, pages 149-154.
Crossref
Crossref
E. Andreadou, E. Kemanetzoglou, Ch. Brokalaki, M. E. Evangelopoulos, C. Kilidireas, A. Rombos & E. Stamboulis. (2013) Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature. Case Reports in Neurological Medicine 2013, pages 1-9.
Crossref
Crossref
Melissa A. Landek-Salgado, Noel R. Rose & Patrizio Caturegli. (2012) Placenta suppresses experimental autoimmune hypophysitis through soluble TNF receptor 1. Journal of Autoimmunity 38:2-3, pages J88-J96.
Crossref
Crossref
Andrew J SolomonRebecca I SpainMichael C KruerDennis Bourdette. (2011) Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors. Multiple Sclerosis Journal 17:12, pages 1472-1487.
Crossref
Crossref
María Cruz Fernández-Espartero, Beatriz Pérez-Zafrilla, Antonio Naranjo, Carmen Esteban, Ana M. Ortiz, Juan J. Gómez-Reino & Loreto Carmona. (2011) Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review. Seminars in Arthritis and Rheumatism 41:3, pages 524-533.
Crossref
Crossref
Kenkichi Nozaki, David E. Stickler, Nada G. Abou-Fayssal, Pierre Giglio, Richard M. Silver, Diane L. Kamen, Rodney Daniel & Marc A. Judson. (2011) Neurological Deficits During Treatment With Tumor Necrosis Factor-Alpha Antagonists. The American Journal of the Medical Sciences 342:5, pages 352-355.
Crossref
Crossref
Juergen Braun & Xenofon Baraliakos. (2009) Treatment of ankylosing spondylitis and other spondyloarthritides. Current Opinion in Rheumatology 21:4, pages 324-334.
Crossref
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:3.
Crossref
Crossref